Cardiac hypertrophy and impaired contractility are associated with decreased ACE2, whereas ACE2 over-expression protects the heart from Ang II-mediated cardiac hypertrophy and myocardial fibrosis (Bodiga et al., 2011; Patel et al., 2012). This evidence concerns the gene ACE2 and Myocardial fibrosis.